| 000 | 01684 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514202009.0 | ||
| 264 | 0 | _c20041129 | |
| 008 | 200411s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.48.10.3765-3772.2004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPletz, Mathias W R | |
| 245 | 0 | 0 |
_aErtapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cOct 2004 |
||
| 300 |
_a3765-72 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCeftriaxone _xadverse effects |
| 650 | 0 | 4 |
_aCephalosporins _xadverse effects |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aErtapenem |
| 650 | 0 | 4 |
_aFeces _xmicrobiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntestines _xdrug effects |
| 650 | 0 | 4 |
_aLactams _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMass Spectrometry |
| 650 | 0 | 4 | _aSex Characteristics |
| 650 | 0 | 4 | _abeta-Lactams |
| 700 | 1 | _aRau, Mareike | |
| 700 | 1 | _aBulitta, Juergen | |
| 700 | 1 | _aDe Roux, Andres | |
| 700 | 1 | _aBurkhardt, Olaf | |
| 700 | 1 | _aKruse, Guido | |
| 700 | 1 | _aKurowski, Michael | |
| 700 | 1 | _aNord, Carl E | |
| 700 | 1 | _aLode, Hartmut | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 48 _gno. 10 _gp. 3765-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.48.10.3765-3772.2004 _zAvailable from publisher's website |
| 999 |
_c15081364 _d15081364 |
||